|
Volumn 163, Issue , 2003, Pages
|
Mouse skin as a model for cancer chemoprevention by nonsteroidal anti-inflammatory drugs.
a a a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
CYCLOOXYGENASE 2;
CYCLOOXYGENASE 2 INHIBITOR;
ISOENZYME;
NONSTEROID ANTIINFLAMMATORY AGENT;
PROSTAGLANDIN;
PROSTAGLANDIN SYNTHASE;
PROSTAGLANDIN SYNTHASE INHIBITOR;
ANIMAL;
BIOSYNTHESIS;
DISEASE MODEL;
DRUG EFFECT;
ENZYMOLOGY;
EXPERIMENTAL NEOPLASM;
GENE EXPRESSION;
GENETICS;
METABOLISM;
MOUSE;
PATHOLOGY;
PHENOTYPE;
PRECANCER;
REVIEW;
SKIN;
SKIN TUMOR;
TRANSGENIC MOUSE;
ANIMALS;
ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL;
CYCLOOXYGENASE 2;
CYCLOOXYGENASE 2 INHIBITORS;
CYCLOOXYGENASE INHIBITORS;
DISEASE MODELS, ANIMAL;
GENE EXPRESSION;
ISOENZYMES;
MICE;
MICE, TRANSGENIC;
NEOPLASMS, EXPERIMENTAL;
PHENOTYPE;
PRECANCEROUS CONDITIONS;
PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES;
PROSTAGLANDINS;
SKIN;
SKIN NEOPLASMS;
MLCS;
MLOWN;
|
EID: 0642283618
PISSN: 00800015
EISSN: None
Source Type: Journal
DOI: 10.1007/978-3-642-55647-0_5 Document Type: Review |
Times cited : (20)
|
References (85)
|